On September 8, a delegation composed of leading enterprises and academic institutions from Turkey's biopharmaceutical, medical device, and healthcare services sectors visited Starfish Medicine & Health Innovation Park. The delegation conducted field inspections of the Park's benchmark enterprises and innovation platforms, including VJTBio. As the Park's only high-quality enterprise dedicated to the animal veterinary drug sector, VJTBio warmly received the distinguished Turkish delegates and engaged in enthusiastic discussions.

During the discussions, VJTBio introduced its core business areas and R&D capabilities to the Turkish delegation. The Turkish business representatives showed strong interest in VJTBio's strategic direction and technological achievements. This visit not only provided the Turkish companies with a direct understanding of the innovative accomplishments in China's animal drug sector but also laid a solid foundation for the future expansion of VJTBio's overseas business.